Drug Channel Dynamics
The discussion delves into the intricate drug channel, highlighting the roles of key stakeholders such as manufacturers, payers, and pharmacy benefit managers. Adam emphasizes the unique financial flows that differentiate pharmaceuticals from other healthcare components, and he explores opportunities for innovation within this complex landscape. The conversation sheds light on how entities like GoodRx and the Mark Cuban Cost Plus Drug Company fit into the existing system, offering insights into the potential for change in the pharmaceutical industry.In this clip
From this podcast
Raising Health
The Consolidated Drug Channel and Cash-Pay Drugs
Related Questions
How do pharmacy benefit managers (PBMs) really make money in the episode The Consolidated Drug Channel and Cash-Pay Drugs and the clip Pharmacy Innovation Challenges?
How do pharmacy benefit managers (PBMs) really make money in the episode The Consolidated Drug Channel and Cash-Pay Drugs and the clip Pharmacy Innovation Challenges?
How do pharmacy benefit managers (PBMs) really make money in the context of the episode The Consolidated Drug Channel and Cash-Pay Drugs and the clip 340B Program Challenges?